How to make tissue microarrays

Diagnostic Histopathology

Volumn 15, Issue 3, 2009, Pages 142-150

  Parsons, Mike ^a   Grabsch, Heike ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

construction; design, quality control; tissue microarray

Indexed keywords

PARAFFIN;

ARTICLE; COLON CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; COST EFFECTIVENESS ANALYSIS; HISTOPATHOLOGY; HUMAN; QUALITY CONTROL; TISSUE MICROARRAY;

EID: 61749096238     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2009.01.010     Document Type: Article

References (73)

1. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4 (1998) 844-847
2. Yan P., Seelentag W., Bachmann A., and Bosman F.T. An agarose matrix facilitates sectioning of tissue microarray blocks. J Histochem Cytochem 55 (2007) 21-24
3. Packeisen J., Buerger H., Krech R., and Boecker W. Tissue microarrays: a new approach for quality control in immunohistochemistry. J Clin Pathol 55 (2002) 613-615
4. Hsu F.D., Nielsen T.O., Alkushi A., et al. TMAs are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 15 (2002) 1374-1380
5. Fitzgibbons P.L., Murphy D.A., Dorfman D.M., Roche P.C., and Tubbs R.R. Interlaboratory comparison of immunohistochemical testing for HER2: results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray Survey. Arch Pathol Lab Med 130 (2006) 1440-1445
6. Chung G.G., Zerkowski M.P., Ghosh S., Camp R.L., and Rimm D.L. Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest 87 (2007) 662-669
7. Dorfman D.M., Bui M.M., Tubbs R.R., et al., College of American Pathologists Cell Markers Committee. The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee Study. Arch Pathol Lab Med 130 (2006) 779-782
8. Mengel M., Hebel K., Kreipe H., and von Wasielewski R. Standardized on-slide control for quality assurance in the immunohistochemical assessment of therapeutic target molecules in breast cancer. Breast J 11 (2005) 34-40
9. Hammer A.S., Dietz H.H., and Hamilton-Dutoit S. Immunohistochemical detection of 3 viral infections in paraffin-embedded tissue from mink (Mustela vison): a tissue-microarray-based study. Can J Vet Res 71 (2007) 8-13
10. Borel N., Mukhopadhyay S., Kaiser C., et al. Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infection. BMC Infect Dis 6 (2006) 152
11. Chan J.K., Wong C.S., Ku W.T., and Kwan M.Y. Reflections on the use of controls in immunohistochemistry and proposal for application of a multitissue spring-roll control block. Ann Diagn Pathol 4 (2000) 329-336
12. Wan W.H., Fortuna M.B., and Furmanski P. A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods 103 (1987) 121-129
13. Howat W.J., Warford A., Mitchell J.N., Clarke K.F., Conquer J.S., and McCafferty J. Resin tissue microarrays: a universal format for immunohistochemistry. J Histochem Cytochem 53 (2005) 1189-1197
14. Zhou L., Hodeib M., Abad J.D., Mendoza L., Kore A.R., and Hu Z. New tissue microarray technology for analyses of gene expression in frozen pathological samples. Biotechniques 43 (2007) 101-105
15. Schoenberg Fejzo M., and Slamon D.J. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am J Pathol 159 (2001) 1645-1650
16. Kyläniemi M., Koskinen M., Karhunen P., Rantala I., Peltola J., and Haapasalo H. A novel frozen brain tissue array technique: immunohistochemical detection of neuronal paraneoplastic autoantibodies. Neuropathol Appl Neurobiol 30 (2004) 39-45
17. Waterworth A., Hanby A., and Speirs V. A novel cell array technique for high-throughput, cell-based analysis. In Vitro Cell Dev Biol Anim 41 (2005) 185-187
18. Wirth G.J., Schandelmaier K., Smith V., Burger A.M., and Fiebig H.H. Microarrays of 41 human tumor cell lines for the characterization of new molecular targets: expression patterns of cathepsin B and the transferrin receptor. Oncology 71 (2006) 86-94
19. Ferrer B., Bermudo R., Thomson T., et al. Paraffin-embedded cell line microarray (PECLIMA): development and validation of a high-throughput method for antigen profiling of cell lines. Pathobiology 72 (2005) 225-232
20. Andersson A.C., Strömberg S., Bäckvall H., et al. Analysis of protein expression in cell microarrays: a tool for antibody-based proteomics. J Histochem Cytochem 54 (2006) 1413-1423
21. Wen C.H., Su Y.C., Wang S.L., Yang S.F., and Chai C.Y. Application of the microarray technique to cell blocks. Acta Cytol 51 (2007) 42-46
22. Egervari K., Szollosi Z., and Nemes Z. Tissue microarray technology in breast cancer HER2 diagnostics. Pathol Res Pract 203 (2007) 169-177
23. Skacel M., Siva A., Xu B., and Tubbs R.R. From array to array: confirmation of genomic gains and losses discovered by array-based comparative genomic hybridization utilizing fluorescence in situ hybridization on tissue microarrays. J Mol Histol 38 (2007) 135-140
24. Dubé V., Grigull J., DeSouza L.V., et al. Verification of endometrial tissue biomarkers previously discovered using mass spectrometry-based proteomics by means of immunohistochemistry in a tissue microarray format. J Proteome Res 6 (2007) 2648-2655
25. Bubendorf L., Kolmer M., Kononen J., et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 91 (1999) 1758-1764
26. Hewitt S.M. The application of tissue microarrays in the validation of microarray results. Meth Enzymol 410 (2006) 400-415
27. Kallioniemi O.P., Wagner U., Kononen J., and Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 10 (2001) 657-662
28. Lorente Garín J.A., Lloreta Trull J., Allepuz Losa C., Plaza Mas L., Rioja Sanz L.A., and Gelabert Mas A. Development of a tissue microarray (TMA) for immunohistochemical study of molecular expression profiling in prostate cancer (Part 1). Actas Urol Esp 30 (2006) 25-32
29. Venkataraman G., and Ananthanaranayanan V. Tissue microarrays: Potential in the Indian subcontinent. Indian J Cancer 42 (2005) 9-14
30. Henriksen K.L., Rasmussen B.B., Lykkesfeldt A.E., Møller S., Ejlertsen B., and Mouridsen H.T. Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays. J Clin Pathol 60 (2007) 397-404
31. Chen W.-C., Lin M.-S., Zhang B.-F., et al. Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray. World J Gastroenterol 13 (2007) 699-708
32. Richani K., Romero R., Kim Y.M., et al. Tissue microarray: an effective high-throughput method to study the placenta for clinical and research purposes. J Matern Fetal Neonatal Med 19 (2006) 509-515
33. Goldstine J., Seligson D.B., Beizai P., Miyata H., and Vinters H.V. Tissue microarrays in the study of non-neoplastic disease of the nervous system. J Neuropathol Exp Neurol 61 (2002) 653-662
34. Torhorst J., Bucher C., Kononen J., et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159 (2001) 2249-2256
35. Sauter G., and Mirlacher M. Tissue microarrays for predictive molecular pathology. J Clin Pathol 55 (2002) 575-576
36. Kyndi M., Sørensen F.B., Knudsen H., et al. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c. Acta Oncol 47 (2008) 591-599
37. Hoos A., and Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: Opportunities and limitations. Lab Invest 81 (2001) 1331-1338
38. Hoos A., Urist M.J., Stojadinovic A., et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 158 (2001) 1245-1251
39. Gillett C.E., Springall R.J., Barnes D.M., and Hanby A.M. Multiple tissue core arrays in histopathology research: a validation study. J Pathol 192 (2000) 549-553
40. Leversha M.A., Fielding P., Watson S., Gosney J.R., and Field J.K. Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. J Pathol 200 (2003) 610-619
41. Boone J., van Hillegersberg R., van Diest P.J., Offerhaus G.J., Rinkes I.H., and Kate F.J. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch 452 (2008) 507-514
42. Keller S.M., Keller B.C., Grest P., Börger C.T., and Guscetti F. Validation of tissue microarrays for immunohistochemical analyses of canine lymphomas. J Vet Diagn Invest 19 (2007) 652-659
43. Singh S.S., Mehedint D.C., Ford III O.H., Maygarden S.J., Ruiz B., and Mohler J.L. Feasibility of constructing tissue microarrays from diagnostic prostate biopsies. Prostate 67 (2007) 1011-1018
44. Fons G., Hasibuan S.M., van der Velden J., and ten Kate F.J. Validation of tissue microarray technology in endometrioid cancer of the endometrium. J Clin Pathol 60 (2007) 500-503
45. Gomaa W., Ke Y., Fujii H., and Helliwell T. Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67. Virchows Arch 447 (2005) 701-709
46. Engellau J., Bendahl P.O., Persson A., et al. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum Pathol 36 (2005) 994-1002
47. Bhargava R., Lal P., and Chen B. Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma. Diagn Mol Pathol 13 (2004) 213-216
48. Rosen D.G., Huang X., Deavers M.T., Malpica A., Silva E.G., and Liu J. Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol 17 (2004) 790-797
49. Van den Eynden G.G., Van der Auwera I., Van Laere S., et al. Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Res Treat 85 (2004) 13-22
50. Pacifico M.D., Grover R., Richman P., Daley F., and Wilson G.D. Validation of tissue microarray for the immunohistochemical profiling of melanoma. Melanoma Res 14 (2004) 39-42
51. Griffin M.C., Robinson R.A., and Trask D.K. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx. Mod Pathol 16 (2003) 1181-1188
52. Chen B., van den Brekel M.W., Buschers W., Balm A.J., and van Velthuysen M.L. Validation of tissue array technology in head and neck squamous cell carcinoma. Head Neck 25 (2003) 922-930
53. Jourdan F., Sebbagh N., Comperat E., et al. Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 443 (2003) 115-121
54. Gulmann C., Butler D., Kay E., Grace A., and Leader M. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 42 (2003) 70-76
55. Fernebro E., Dictor M., Bendahl P.O., Fernö M., and Nilbert M. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch Pathol Lab Med 126 (2002) 702-705
56. Camp R.L., Charette L.A., and Rimm D.L. Validation of tissue microarray technology in breast carcinoma. Lab Invest 80 (2000) 1943-1949
57. Gulmann C., and O'Grady A. Tissue microarrays: an overview. Curr Diagn Pathol 9 (2003) 149-154
58. Goethals L., Perneel C., Debucquoy A., et al. A new approach to the validation of tissue microarrays. J Pathol 208 (2006) 607-614
59. Mucci N.R., Akdas G., Manely S., and Rubin M.A. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol 31 (2000) 778
60. Richter J., Wagner U., Kononen J., et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 157 (2000) 787-794
61. Schraml P., Kononen J., Bubendorf L., et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5 (1999) 1966-1975
62. Hager M., Kolbitsch C., Tiefenthaler W., Haufe H., Kemmerling R., and Lucia Moser P. Tissue microarrays from renal cell tumors: exclusion criteria and rate of exclusion. Scand J Urol Nephrol 41 (2007) 485-489
63. Datta M.W., Kahler A., Macias V., Brodzeller T., and Kajdacsy-Balla A. A simple inexpensive method for the production of tissue microarrays from needle biopsy specimens: examples with prostate cancer. Appl Immunohistochem Mol Morphol 13 (2005) 96-103
64. Vogel U.F., and Bueltmann B.D. Simple, inexpensive, and precise paraffin tissue microarrays constructed with a conventional microcompound table and a drill grinder. Am J Clin Pathol 126 (2006) 342-348
65. Vogel U.F. The construction of high-density paraffin tissue microarrays with 0.43-mm-diameter paraffin tissue core biopsies is technically feasible. Virchows Arch 453 (2008) 43-46
66. Pan C.C., Chen P.C., and Chiang H. An easy method for manual construction of high-density tissue arrays. Appl Immunohistochem Mol Morphol 12 (2004) 370-372
67. Kramer M.W., Merseburger A.S., Hennenlotter J., and Kuczyk M. Tissue microarrays in clinical urology - technical considerations. Scand J Urol Nephrol 41 (2007) 478-484
68. Bubendorf L., Kononen J., Koivisto P., et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res 59 (1999) 803-806
69. Moch H., Schraml P., Bubendorf L., et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154 (1999) 981-986
70. Rimm D.L., Camp R.L., Charette L.A., Olsen D.A., and Provost E. Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol 70 (2001) 255-264
71. Conway C., Dobson L., O'Grady A., Kay E., Costello S., and O'Shea D. Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs. Histochem Cell Biol 130 (2008) 447-463
72. Battifora H. Assessment of antigen damage in immunohistochemistry. The vimentin internal control. Am J Clin Pathol 96 (1991) 669-671
73. Parsons M, Scott N, Kavi V, et al. Tissue microarray quality control prior to their use - results from an internation interobserver study. Summer meeting of the Pathological Society of Great Britain and Ireland, Glasgow, 2007.